Overview

Clinical Efficacy of Fosfomycin Trometamol Per os in the Treatment of Documented Male Urinary Tract Infections With ESBL-producing Enterobacteriaceae With ESBL Producing Enterobacteriaceae and Resistance Associated With Fluoroquinolones and Cotrimox

Status:
Unknown status

Trial end date:
2021-09-01

Target enrollment:

Participant gender:

Summary

The aim of the study was to evaluate the clinical and microbiological efficacy of fosfomycin trometamol (FT) per os in the treatment of documented male urinary tract infections with ESBL-producing enterobacteriaceae

Phase:

Phase 2

Details

Lead Sponsor:

Centre Hospitalier Universitaire de Besancon

Treatments:

Fluoroquinolones
Fosfomycin
Trimethoprim, Sulfamethoxazole Drug Combination